Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiahui Health has established itself as an international-standard medical ecosystem in China. It provides comprehensive healthcare services including health management, emergency care, surgery, inpatient/outpatient services. Through partnerships with companies like IASO Biotechnology and Fosun Kite, it offers BCMA-targeted CAR-T cell therapy for relapsed/refractory multiple myeloma and has successfully treated both domestic and foreign patients at its Shanghai-based cancer center. The first foreign lymphoma patient was treated with Akilenza Injection CAR-T at the facility in 2023.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiahui Health.